A molecular tweezer antagonizes seminal amyloids and HIV infection

eLife

Volumn 4, Issue AUGUST2015, 2015, Pages

  Lump, Edina ^a   Castellano, Laura M ^b   Meier, Christoph ^c   Seeliger, Janine ^d   Erwin, Nelli ^d   Sperlich, Benjamin ^d   Stürzel, Christina M ^a   Usmani, Shariq ^a   Hammond, Rebecca M ^b,e   Von Einem, Jens ^a   Gerold, Gisa ^f   Kreppel, Florian ^a   Bravo Rodriguez, Kenny ^g   Pietschmann, Thomas ^f   Holmes, Veronica M ^b   Palesch, David ^a   Zirafi, Onofrio ^a   Weissman, Drew ^b   Sowislok, Andrea ^h   Wettig, Burkhard ^h   Heid, Christian ^h   Kirchhoff, Frank ^a,c   Weil, Tanja ^c   Klärner, Frank Gerrit ^h   Schrader, Thomas ^h   Bitan, Gal ^i,j   Sanchez Garcia, Elsa ^g   Winter, Roland ^d   Shorter, James ^b   Munch, Jan ^c   more..

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d TU DORTMUND UNIVERSITY   (Germany)

^e SWARTHMORE COLLEGE   (United States)

^f INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^g MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

^h UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; ARGININE; CLR 01; CLR 03; LYSINE; UNCLASSIFIED DRUG; AMYLOID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMETABOLITE; BRIDGED COMPOUND; CLR01 COMPOUND; ORGANOPHOSPHATE;

ANTIVIRAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL VIABILITY; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; CRITICAL MICELLE CONCENTRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 2; HOST PATHOGEN INTERACTION; HUMAN ADENOVIRUS 5; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR TWEEZER; MOLECULE; PROTEIN AGGREGATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SPERM; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INFECTIVITY; ZETA POTENTIAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DISEASE TRANSMISSION; DRUG EFFECTS; HIV INFECTIONS; HUMAN; MALE; PREVENTION AND CONTROL; TRANSMISSION; VIROLOGY;

AMYLOID; ANTI-HIV AGENTS; ANTIMETABOLITES; BRIDGED-RING COMPOUNDS; DISEASE TRANSMISSION, INFECTIOUS; HIV INFECTIONS; HUMANS; MALE; ORGANOPHOSPHATES; SEMEN;

EID: 84940498985     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.05397     Document Type: Article

References (96)

1. Acharya S, Safaie BM, Wongkongkathep P, Ivanova MI, Attar A, Klarner FG, Schrader T, Loo JA, Bitan G, Lapidus LJ. 2014. Molecular basis for preventing alpha-synuclein aggregation by a molecular tweezer. The Journal of Biological Chemistry 289:10727-10737. doi: 10.1074/jbc.M113.524520.
2. Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM. 1988. Lipid composition and fluidity of the human immunodeficiency virus. Proceedings of the National Academy of Sciences of USA 85:900-904. doi: 10.1073/ pnas.85.3.900.
3. Arnold F, Schnell J, Zirafi O, Stürzel C, Meier C, Weil T, Ständker L, Forssmann WG, Roan NR, Greene WC, Kirchhoff F, Münch J. 2012. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. Journal of Virology 86:1244-1249. doi: 10.1128/JVI.06121-11.
4. Attar A, Chan WT, Klarner FG, Schrader T, Bitan G. 2014. Safety and pharmacological characterization of the molecular tweezer CLR01-a broad-spectrum inhibitor of amyloid proteins' toxicity. BMC Pharmacology & Toxicology 15:23. doi: 10.1186/2050-6511-15-23.
5. Attar A, Ripoli C, Riccardi E, Maiti P, Li Puma DD, Liu T, Hayes J, Jones MR, Lichti-Kaiser K, Yang F, Gale GD, Tseng CH, Tan M, Xie CW, Straudinger JL, Klärner FG, Schrader T, Frautschy SA, Grassi C, Bitan G. 2012. Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers. Brain 135:3735-3748. doi: 10.1093/brain/aws289.
6. Bier D, Rose R, Bravo-Rodriguez K, Bartel M, Ramirez-Anguita JM, Dutt S, Wilch C, Klärner FG, Sanchez-Garcia E, Schrader T, Ottmann C. 2013. Molecular tweezers modulate 14-3-3 protein-protein interactions. Nature Chemistry 5:234-239. doi: 10.1038/nchem.1570.
7. Bjelkmar P, Larsson P, Cuendet MA, Hess B, Lindahl E. 2010. Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models. Journal of Chemical Theory and Computation 6:459-466. doi: 10.1021/ct900549r.
8. Brügger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG. 2006. The HIV lipidome: a raft with an unusual composition. Proceedings of the National Academy of Sciences of USA 103:2641-2646. doi: 10.1073/ pnas.0511136103.
9. Castellano LM, Shorter J. 2012. The surprising role of amyloid fibrils in HIV infection. Biology 1:58-80. doi: 10. 3390/biology1010058.
10. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR. 2008. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. Journal of Virology 82:11228-11238. doi: 10.1128/ JVI.00981-08.
11. Coan KE, Shoichet BK. 2007. Stability and equilibria of promiscuous aggregates in high protein milieus. Molecular Biosystems 3:208-213. doi: 10.1039/b616314a.
12. Daura X, Gademann K, Jaun B, Seebach D, van Gunsteren WF, Mark AE. 1999. Peptide folding: when simulation meets experiment. Angewandte Chemie International Edition 38:236-240.
13. Dutt S, Wilch C, Gersthagen T, Talbiersky P, Bravo-Rodriguez K, Hanni M, Sanchez-Garcia E, Ochsenfeld C, Klarner FG, Schrader T. 2013. Molecular tweezers with varying anions: a comparative study. The Journal of Organic Chemistry 78:6721-6734. doi: 10.1021/jo4009673.
14. Feng BY, Toyama BH, Wille H, Colby DW, Collins SR, May BC, Prusiner SB, Weissman J, Shoichet BK. 2008. Smallmolecule aggregates inhibit amyloid polymerization. Nature Chemical Biology 4:197-199. doi: 10.1038/ nchembio.65.
15. Ferreira N, Pereira-Henriques A, Attar A, Klarner FG, Schrader T, Bitan G, Gales L, Saraiva MJ, Almeida MR. 2014. Molecular tweezers targeting transthyretin amyloidosis. Neurotherapeutics 11:450-461. doi: 10.1007/s13311-013-0256-8.
16. Fokkens M, Schrader T, Klarner FG. 2005. A molecular tweezer for lysine and arginine. Journal of the American Chemical Society 127:14415-14421. doi: 10.1021/ja052806a.
17. French KC, Makhatadze GI. 2012. Core sequence of PAPf39 amyloid fibrils and mechanism of pH-dependent fibril formation: the role of monomer conformation. Biochemistry 51:10127-10136. doi: 10.1021/bi301406d.
18. Frohm B, DeNizio JE, Lee DS, Gentile L, Olsson U, Malm J, Akerfeldt KS, Linse S. 2015. A peptide from human semenogelin I self-assembles into a pH-responsive hydrogel. Soft Matter 11:414-421. doi: 10.1039/c4sm01793e.
19. Gerl MJ, Sampaio JL, Urban S, Kalvodova L, Verbavatz JM, Binnington B, Lindemann D, Lingwood CA, Shevchenko A, Schroeder C, Simons K. 2012. Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. The Journal of Cell Biology 196:213-221. doi: 10.1083/jcb.201108175.
20. Goldschmidt L, Teng PK, Riek R, Eisenberg D. 2010. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proceedings of the National Academy of Sciences of USA 107:3487-3492. doi: 10.1073/pnas. 0915166107.
21. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC, Rakai Project Team. 2001. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149-1153. doi: 10. 1016/S0140-6736(00)04331-2.
22. Haid S, NovodomskáA, Gentzsch J, Grethe C, Geuenich S, Bankwitz D, Chhatwal P, Jannack B, Hennebelle T, Bailleul F, Keppler OT, Poenisch M, Bartenschlager R, Hernandez C, Lemasson M, Rosenberg AR, Wong-Staal F, Davioud-Charvet E, Pietschmann T. 2012. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 143:213-222. e5. doi: 10.1053/j.gastro.2012.03.036.
23. Handsfield HH, Chandler SH, Caine VA, Meyers JD, Corey L, Medeiros E, McDougall JK. 1985. Cytomegalovirus infection in sex partners: evidence for sexual transmission. The Journal of Infectious Diseases 151:344-348. doi: 10.1093/infdis/151.2.344.
24. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. 2009. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proceedings of the National Academy of Sciences of USA 106:9033-9038. doi: 10.1073/pnas.0811827106.
25. Herzog G, Shmueli MD, Levy L, Engel L, Gazit E, Klarner FG, Schrader T, Bitan G, Segal D. 2015. The Lys-specific molecular tweezer, CLR01, modulates aggregation of the mutant p53 DNA binding domain and inhibits its toxicity. Biochemistry. doi: 10.1021/bi501092p.
26. Hess B, Kutzner C, van der Spoel D, Lindahl E. 2008. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation 4:435-447. doi: 10.1021/ ct700301q.
27. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics 79:926-935. doi: 10.1063/1.445869.
28. Kim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Münch J. 2010. Semen-mediated enhancement of HIV infection is donordependent and correlates with the levels of SEVI. Retrovirology 7:55. doi: 10.1186/1742-4690-7-55.
29. Klärner FG, Kahlert B, Nellesen A, Zienau J, Ochsenfeld C, Schrader T. 2006. Molecular tweezer and clip in aqueous solution: unexpected self-assembly, powerful host-guest complex formation, quantum chemical 1H NMR shift calculation. Journal of the American Chemical Society 128:4831-4841. doi: 10.1021/ja058410g.
30. Klärner FG, Schrader T. 2013. Aromatic interactions by molecular tweezers and clips in chemical and biological systems. Accounts of Chemical Research 46:967-978. doi: 10.1021/ar300061c.
31. Klärner FG, Schrader T, Polkowska J, Bastkowski F, Talbiersky P, Campana Kuchenbrandt M, Schaller T, de Groot H, Kirsch M. 2010. Effect of molecular clips and tweezers on enzymatic reactions by binding coenzymes and basic amino acids. Pure and Applied Chemistry 82:991-999.
32. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. Journal of Virology 80:5308-5320. doi: 10.1128/JVI.02460-05.
33. Kreppel F, Biermann V, Kochanek S, Schiedner G. 2002. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Human Gene Therapy 13:1151-1156. doi: 10.1089/104303402320138934.
34. Lazo ND, Grant MA, Condron MC, Rigby AC, Teplow DB. 2005. On the nucleation of amyloid beta-protein monomer folding. Protein Science 14:1581-1596. doi: 10.1110/ps.041292205.
35. Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. doi: 10.1126/science.1114016.
36. Lockhart A, Ye L, Judd DB, Merritt AT, Lowe PN, Morgenstern JL, Hong G, Gee AD, Brown J. 2005. Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on beta-amyloid peptide fibrils. The Journal of Biological Chemistry 280:7677-7684. doi: 10.1074/jbc.M412056200.
37. Lopes DH, Attar A, Nair G, Hayden EY, Du Z, McDaniel K, Dutt S, Bravo-Rodriguez K, Mittal S, Klärner FG,Wang C, Sanchez-Garcia E, Schrader T, Bitan G. 2015. Molecular tweezers inhibit islet amyloid polypeptide assembly and toxicity by a new mechanism. ACS Chemical Biology. doi: 10.1021/acschembio.5b00146.
38. Lorizate M, Brügger B, Akiyama H, Glass B, Muller B, Anderluh G, Wieland FT, Krausslich HG. 2009. Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. The Journal of Biological Chemistry 284:22238-22247. doi: 10.1074/jbc.M109.029256.
39. Lorizate M, Sachsenheimer T, Glass B, Habermann A, Gerl MJ, Krausslich HG, Brügger B. 2013. Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cellular Microbiology 15:292-304. doi: 10.1111/cmi.12101.
40. Lüscher-Mattli M. 2000. Polyanions-a lost chance in the fight against HIV and other virus diseases? Antiviral Chemistry & Chemotherapy 11:249-259. doi: 10.1177/095632020001100401.
41. Mackerell AD Jr, Feig M, Brooks CL III. 2004. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. Journal of Computational Chemistry 25:1400-1415. doi: 10.1002/jcc.20065.
42. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, Grossman C, Rooney J, Schwartz JL, Watts H, Marzinke MA, Hillier SL, McGowan IM, Chirenje ZM, VOICE Study Team. 2015. Tenofovir-based preexposure prophylaxis for HIV infection among African women. The New England Journal of Medicine 372:509-518. doi: 10.1056/NEJMoa1402269.
43. McGovern SL, Caselli E, Grigorieff N, Shoichet BK. 2002. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. Journal of Medicinal Chemistry 45:1712-1722. doi: 10.1021/ jm010533y.
44. McGovern SL, Helfand BT, Feng B, Shoichet BK. 2003. A specific mechanism of nonspecific inhibition. Journal of Medicinal Chemistry 46:4265-4272. doi: 10.1021/jm030266r.
45. McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C, MTN-004 Protocol Team. 2011. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS 25:1057-1064. doi: 10.1097/QAD. 0b013e328346bd3e.
46. Merz A, Long G, Hiet MS, Brügger B, Chlanda P, Andre P, Wieland F, Krijnse-Locker J, Bartenschlager R. 2011. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. The Journal of Biological Chemistry 286:3018-3032. doi: 10.1074/jbc.M110.175018.
47. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, Hendrickx AG. 1994. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. Journal of Virology 68:6391-6400.
48. Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimé nez-Gallego G, Sánchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F. 2007. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131: 1059-1071. doi: 10.1016/j.cell.2007.10.014.
49. Münch J, Sauermann U, Yolamanova M, Raue K, Stahl-Hennig C, Kirchhoff F. 2013. Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus. Retrovirology 10:148. doi: 10.1186/1742-4690-10-148.
50. Münch J, Standker L, ForssmannWG, Kirchhoff F. 2014. Discovery of modulators of HIV-1 infection from the human peptidome. Nature Reviews. Microbiology 12:715-722. doi: 10.1038/nrmicro3312.
51. Nanga RP, Brender JR, Vivekanandan S, Popovych N, Ramamoorthy A. 2009. NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286). Journal of the American Chemical Society 131:17972-17979. doi: 10.1021/ja908170s.
52. Neildez O, Le Grand R, Cheret A, Caufour P, Vaslin B,Matheux F, Theodoro F, Roques P, Dormont D. 1998. Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251. Research in Virology 149:53-68. doi: 10.1016/S0923-2516(97)86900-2.
53. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. 2005. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435:773-778. doi: 10.1038/nature03680.
54. Neurath AR, Strick N, Li YY. 2002. Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides. BMC Infectious Diseases 2:27. doi: 10.1186/1471-2334-2-27.
55. Neurath AR, Strick N, Li YY. 2006. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infectious Diseases 6:150. doi: 10.1186/1471-2334-6-150.
56. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, Salazar-Gonzalez JF, Shattock R, Haynes BF, Shaw GM, Hahn BH, Kappes JC. 2012. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. Journal of Virology 86:2715-2728. doi: 10.1128/JVI.06157-11.
57. Okabe T, Kawata M, Okamoto Y, Mikami M. 2001. Replica-exchange Monte Carlo method for the isobaric-isothermal ensemble. The Journal of Chemical Physics 335:435-439. doi: 10.1016/S0009-2614(01)00055-0.
58. Olsen JS, DiMaio JT, Doran TM, Brown C, Nilsson BL, Dewhurst S. 2012. Seminal plasma accelerates semenderived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide. The Journal of Biological Chemistry 287:11842-11849. doi: 10.1074/jbc.M111.314336.
59. Owen DH, Katz DF. 2005. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. Journal of Andrology 26:459-469. doi: 10.2164/jandrol.04104.
60. Papkalla A, Münch J, Otto C, Kirchhoff F. 2002. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. Journal of Virology 76:8455-8459. doi: 10.1128/JVI.76.16. 8455-8459.2002.
61. Patriksson A, van der Spoel D. 2008. A temperature predictor for parallel tempering simulations. Physical Chemistry Chemical Physics 10:2073-2077. doi: 10.1039/b716554d.
62. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. 2002. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proceedings of the National Academy of Sciences of USA 99:16742-16747. doi: 10.1073/pnas.262663499.
63. Prabhudesai S, Sinha S, Attar A, Kotagiri A, Fitzmaurice AG, Lakshmanan R, Ivanova MI, Loo JA, Klärner FG, Schrader T, Stahl M, Bitan G, Bronstein JM. 2012. A novel 'molecular tweezer' inhibitor of alpha-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics 9:464-476. doi: 10.1007/s13311-012-0105-1.
64. Rapp F. 1989. Sexually transmitted viruses. The Yale Journal of Biology and Medicine 62:173-185.
65. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, Kaderali L, Poenisch M, Blankenburg H, Hiet MS, Longerich T, Diehl S, Ramirez F, Balla T, Rohr K, Kaul A, Bühler S, Pepperkok R, Lengauer T, Albrecht M, Eils R, Schirmacher P, Lohmann V, Bartenschlager R. 2011. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host & Microbe 9:32-45. doi: 10.1016/j.chom.2010.12.002.
66. Roan NR, Müller JA, Liu H, Chu S, Arnold F, Sturzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, Münch J, Greene WC. 2011. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host & Microbe 10:541-550. doi: 10.1016/j.chom.2011.10.010.
67. Roan NR, Münch J. 2015. Improving preclinical models of HIV microbicide efficacy. Trends in Microbiology.
68. Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC. 2009. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. Journal of Virology 83:73-80. doi: 10.1128/JVI.01366-08.
69. Schiedner G, Hertel S, Kochanek S. 2000. Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Human Gene Therapy 11:2105-2116. doi: 10. 1089/104303400750001417.
70. Shattock RJ, Moore JP. 2003. Inhibiting sexual transmission of HIV-1 infection. Nature Reviews. Microbiology 1: 25-34. doi: 10.1038/nrmicro729.
71. Shoichet BK. 2006. Interpreting steep dose-response curves in early inhibitor discovery. Journal of Medicinal Chemistry 49:7274-7277. doi: 10.1021/jm061103g.
72. Sievers Sa, Karanicolas J, Chang HW, Zhao A, Jiang L, Zirafi O, Stevens JT, Münch J, Baker D, Eisenberg D. 2011. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475:96-100. doi: 10.1038/nature10154.
73. Sinha S, Du Z, Maiti P, Klarner FG, Schrader T, Wang C, Bitan G. 2012. Comparison of three amyloid assembly inhibitors: the sugar scyllo-inositol, the polyphenol epigallocatechin gallate, and the molecular tweezer CLR01. ACS Chemical Neuroscience 3:451-458. doi: 10.1021/cn200133x.
74. Sinha S, Lopes DH, Du Z, Pang ES, Shanmugam A, Lomakin A, Talbiersky P, Tennstaedt A, McDaniel K, Bakshi R, Kuo PY, Ehrmann M, Benedek GB, Loo JA, Klärner FG, Schrader T, Wang C, Bitan G. 2011. Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins. Journal of the American Chemical Society 133:16958-16969. doi: 10.1021/ja206279b.
75. Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, Messerle M, Hengel H, Koszinowski U, Brune W, Adler B. 2008. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. The Journal of General Virology 89:359-368. doi: 10.1099/vir.0.83286-0.
76. Sugita Y, Okamoto Y. 1999. Replica-exchange molecular dynamics method for protein folding. Chemical Physics Letters 314:141-151. doi: 10.1016/S0009-2614(99)01123-9.
77. Talbiersky P, Bastkowski F, Klarner FG, Schrader T. 2008. Molecular clip and tweezer introduce new mechanisms of enzyme inhibition. Journal of the American Chemical Society 130:9824-9828. doi: 10.1021/ja801441j.
78. Tedder RS, Gilson RJ, Briggs M, Loveday C, Cameron CH, Garson JA, Kelly GE, Weller IV. 1991. Hepatitis C virus: evidence for sexual transmission. BMJ 302:1299-1302. doi: 10.1136/bmj.302.6788.1299.
79. Tikhonov AN, Arsenin VY. 1977. Solution of III-posed problems. Washington, DC: Halsted Press.
80. Usmani SM, Zirafi O, Müller JA, Sandi-Monroy NL, Yadav JK, Meier C, Weil T, Roan NR, Greene WC, Walther P, Nilsson KP, Hammarström P, Wetzel R, Pilcher CD, Gagsteiger F, Fändrich M, Kirchhoff F, Münch J. 2014. Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. Nature Communications 5:3508. doi: 10.1038/ncomms4508.
81. Van Damme L, Govinden R, Mirembe FM, Gué dou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D, CS Study Group. 2008. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. The New England Journal of Medicine 359:463-472. doi: 10. 1056/NEJMoa0707957.
82. van de Wijgert JH, Shattock RJ. 2007. Vaginal microbicides: moving ahead after an unexpected setback. AIDS 21: 2369-2376. doi: 10.1097/QAD.0b013e3282ef83fd.
83. van Genderen IL, Brandimarti R, Torrisi MR, Campadelli G, van Meer G. 1994. The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei. Virology 200:831-836. doi: 10.1006/viro. 1994.1252.
84. Vigant F, Lee J, Hollmann A, Tanner LB, Akyol Ataman Z, Yun T, Shui G, Aguilar HC, Zhang D, Meriwether D, Roman-Sosa G, Robinson LR, Juelich TL, Buczkowski H, Chou S, Castanho MA, Wolf MC, Smith JK, Banyard A, Kielian M, Reddy S, Wenk MR, Selke M, Santos NC, Freiberg AN, Jung ME, Lee B. 2013. A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion. PLOS Pathogens 9:e1003297. doi: 10.1371/journal. ppat.1003297.
85. Weber J, Desai K, Darbyshire J, Microbicides Development P. 2005. The development of vaginal microbicides for the prevention of HIV transmission. PLOS Medicine 2:e142. doi: 10.1371/journal.pmed.0020142.
86. Weise K, Kapoor S, Denter C, Nikolaus J, Opitz N, Koch S, Triola G, Herrmann A, Waldmann H, Winter R. 2011. Membrane-mediated induction and sorting of K-Ras microdomain signaling platforms. Journal of the American Chemical Society 133:880-887. doi: 10.1021/ja107532q.
87. Weise K, Triola G, Brunsveld L, Waldmann H, Winter R. 2009. Influence of the lipidation motif on the partitioning and association of N-Ras in model membrane subdomains. Journal of the American Chemical Society 131: 1557-1564. doi: 10.1021/ja808691r.
88. Wojcechowskyj JA, Doms RW. 2010. A potent, broad-spectrum antiviral agent that targets viral membranes. Viruses 2:1106-1109. doi: 10.3390/v2051106.
89. Wolf MC, Freiberg AN, Zhang T, Akyol-Ataman Z, Grock A, Hong PW, Li J, Watson NF, Fang AQ, Aguilar HC, Porotto M, Honko AN, Damoiseaux R, Miller JP, Woodson SE, Chantasirivisal S, Fontanes V, Negrete OA, Krogstad P, Dasgupta A, Moscona A, Hensley LE, Whelan SP, Faull KF, Holbrook MR, Jung ME, Lee B. 2010. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences of USA 107:3157-3162. doi: 10.1073/pnas.0909587107.
90. Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, Hoshi M, Nussinov R, Ishii Y. 2015. Abeta(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease. Nature Structural & Molecular Biology 22:499-505. doi: 10.1038/nsmb.2991.
91. Ye Z, French KC, Popova LA, Lednev IK, Lopez MM, Makhatadze GI. 2009. Mechanism of fibril formation by a 39-residue peptide (PAPf39) from human prostatic acidic phosphatase. Biochemistry 48:11582-11591. doi: 10.1021/ bi901709j.
92. Yolamanova M, Meier C, Shaytan AK, Vas V, Bertoncini CW, Arnold F, Zirafi O, Usmani SM, Müller JA, Sauter D, Goffinet C, Palesch D, Walther P, Roan NR, Geiger H, Lunov O, Simmet T, Bohne J, Schrezenmeier H, Schwarz K, Ständker L, Forssmann WG, Salvatella X, Khalatur PG, Khokhlov AR, Knowles TP, Weil T, Kirchhoff F, Münch J. 2013. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nature Nanotechnology 8:130-136. doi: 10.1038/nnano.2012.248.
93. Young LM, Saunders JC, Mahood RA, Revill CH, Foster RJ, Tu LH, Raleigh DP, Radford SE, Ashcroft AE. 2015. Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry. Nature Chemistry 7:73-81. doi: 10.1038/nchem.2129.
94. Zheng X, Liu D, Klarner FG, Schrader T, Bitan G, Bowers MT. 2015. Amyloid beta-protein assembly: the effect of molecular tweezers CLR01 and CLR03. The Journal of Physical Chemistry. B 119:4831-4841. doi: 10.1021/acs. jpcb.5b00692.
95. Zirafi O, Kim KA, Roan NR, Kluge SF, Muller JA, Jiang S, Mayer B, Greene WC, Kirchhoff F, Münch J. 2014. Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides. Science Translational Medicine 6: 262ra157. doi: 10.1126/scitranslmed.3009634.
96. Zoete V, Cuendet MA, Grosdidier A, Michielin O. 2011. SwissParam: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry 32:2359-2368. doi: 10.1002/jcc.21816.